AMPLEXOR Named in Gartner Report ‘Strategic Life Science Regulatory Information Management: From Fragmented to Holistic’
Leading industry analyst report into RIM cites AMPLEXOR Life Sciences as an example of a solution and services vendor that…
Pharmaceuticals, Biotechnology and Life Sciences
Leading industry analyst report into RIM cites AMPLEXOR Life Sciences as an example of a solution and services vendor that…
DUBLIN–(BUSINESS WIRE)–The “Pain Therapeutics – Drugs, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
DUBLIN–(BUSINESS WIRE)–The “Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose),…
New preclinical data to be presented on Core inhibitor EDP-514 targeting HBV FXR agonist EDP-305 targeting NASH ASK-1 inhibitors EP-026856…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together…
DUBLIN–(BUSINESS WIRE)–The “Reporter Gene Assay Market by Reagents & Assay Kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation,…
Novartis on Wednesday said that it got approval from the FDA for Mayzent for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically isolated syndrome, relapsing remitting disease, and active secondary progressive disease, in adults.
WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is focused on tobacco harm reduction and…
SENS-111 phase 2 AUV trial: major progress with 75% of patients enrolled in the clinical trial assessing the efficacy of…
BETHESDA, Md.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/Hyalolex?src=hash” target=”_blank”gt;#Hyalolexlt;/agt;–India Globalization Capital, Inc. (NYSE:IGC) announces today that, as of Wednesday, March 27, 2019, Hyalolex™, the…